Related references
Note: Only part of the references are listed.Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
Aleix Gimeno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Chloroquine and hydroxychloroquine in covid-19
Robin E. Ferner et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19-The real role of NSAIDs in Italy
Laura de Girolamo et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2020)
Artificial intelligence approach fighting COVID-19 with repurposing drugs
Yi-Yu Ke et al.
BIOMEDICAL JOURNAL (2020)
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study
Lars Christian Lund et al.
PLOS MEDICINE (2020)
No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials
Subodh Kumar Pathak et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Lysophosphatidylcholine-induced mitochondrial fission contributes to collagen production in human cardiac fibroblasts[S]
Hui-Ching Tseng et al.
JOURNAL OF LIPID RESEARCH (2019)
The ER stress sensor IRE1 and MAP kinase ERK modulate autophagy induction in cells infected with coronavirus infectious bronchitis virus
To Sing Fung et al.
VIROLOGY (2019)
Cytokines trigger disruption of endothelium barrier function and p38 MAP kinase activation in BMPR2-silenced human lung microvascular endothelial cells
Birger Tielemans et al.
PULMONARY CIRCULATION (2019)
Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury
Todd R. Harris et al.
MOLECULAR PHARMACOLOGY (2018)
Attenuation of antimalarial agent hydroxychloroquine on TNF-α-induced endothelial inflammation
Ruiru Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression
Nina Kim et al.
JOURNAL OF IMMUNOLOGY (2018)
Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project
Gwen M. C. Masclee et al.
PLOS ONE (2018)
Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease
Mohit Kumar Jolly et al.
DEVELOPMENTAL DYNAMICS (2018)
Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology
Nathan Rout-Pitt et al.
RESPIRATORY RESEARCH (2018)
Inhibition of P38 MAPK Downregulates the Expression of IL-1β to Protect Lung from Acute Injury in Intestinal Ischemia Reperfusion Rats
De-Yi Zheng et al.
MEDIATORS OF INFLAMMATION (2016)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
SB203580 inhibits epithelial-mesenchymal transition and pulmonary fibrosis in a rat silicosis model
Wang Yan et al.
TOXICOLOGY LETTERS (2016)
Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes
Shi-Lei Wen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions
To Sing Fung et al.
VIRUS RESEARCH (2014)
Hyperoxia and Interferon-γ-Induced Injury in Developing Lungs Occur via Cyclooxygenase-2 and the Endoplasmic Reticulum Stress-Dependent Pathway
Rayman Choo-Wing et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection
Li Liu et al.
CLINICA CHIMICA ACTA (2011)
Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
Michelle A. Carey et al.
PLOS ONE (2010)
Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis
Paolo Fabbrini et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
Masakazu Kono et al.
ANTIVIRAL RESEARCH (2008)
Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: A mechanism for the pathogenesis of avian influenza H5N1 infection
Suki M. Y. Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Insights into inflammation and influenza
Cameron Simmons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Bo-Jian Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2
Mo Liu et al.
VIRUS GENES (2006)
Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein
Xiaohong Yan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection
MA Carey et al.
JOURNAL OF IMMUNOLOGY (2005)
The molecular basis for coxib inhibition of p38α MAP kinase
GMS da Silva et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
An interferon-γ-related cytokine storm in SARS patients
KJ Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)